Jon Cherry/Bloomberg via Getty Images, FILE (WASHINGTON) — The Food and Drug Administration’s independent panel of advisers has voted in favor of the FDA authorizing Novavax, a protein-based vaccine, which could soon be the fourth vaccine for COVID-19 authorized in the U.S. Although the U.S. already has three other COVID vaccines, some experts are excited […]

Current track